UCLA Human Genetics
The Department of Human Genetics is the youngest basic science department in the Geffen School of Medicine at UCLA. When the Department was launched just prior to the sequencing of the human genome, it was clear that the practice of genetics research would be forever changed by the infusion of massive amounts of new data. Organizing and making sense of this genomic data is one of the greatest scientific challenges ever faced by mankind. The knowledge generated will ultimately transform medicine through patient-specific treatments and prevention strategies.
The Department is dedicated to turning the mountains of raw genetic data into a detailed understanding of the molecular pathogenesis of human disease. The key to such understanding is the realization that genes not only code for specific proteins, but they also control the temporal development and maturation of every living organism through a complex web of interactions.
Housed in the new Gonda Research Center, the Department serves as a focal point for genetics research on the UCLA campus, with state of the art facilities for gene expression, sequencing, genotyping, and bioinformatics. In addition to its research mission, the Department offers many exciting training opportunities for graduate students, postdoctoral fellows, and medical residents. Our faculty and staff welcome inquiries from prospective students. We also hope that a quick look at our web pages will give you a better idea of the Department's research and educational activities.
- The Football Examiner (Oct. 17), Irish Health (Oct. 19) and Imperial Valley News (Oct. 19) reported on a study by Dr. Steve Horvath that found that obesity ages the liver. The article can be seen here.
- UCLA's Clinical Genomics Center is profiled in U.S. News & World Report's prestigious 2014 "Best Hospitals" edition. The article titled "UCLA's DNA Detectives in Action" talks about cutting-edge work led by UCLA's devoted genetic researchers, clinicians and counselors, and can be seen here.
- Dr. Katrina Dipple, Dr. Stanley Nelson, Dr. Christina Palmer, and Dr. Eric Vilain are co-principal investigators on a grant that has been awarded $7.2 million by the National Institutes of Health. It is part of a $120 million initiative called the Undiagnosed Diseases Network and is geared towards comprehensive clinical research in mystery genetic diseases.